The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model.
about
Local immunomodulation with CD4 and CD8 antibodies, but not cyclosporine A, improves osteogenesis induced by ADhBMP9 gene therapy.Vascular endothelial growth factor inhibits bone morphogenetic protein 2 expression in rat mesenchymal stem cells.Growth factor delivery for bone tissue repair: an update.Safety and efficacy of use of demineralised bone matrix in orthopaedic and trauma surgery.Bone morphogenetic proteins in craniofacial surgery: current techniques, clinical experiences, and the future of personalized stem cell therapy.Transforming growth factor beta 1 augments calvarial defect healing and promotes suture regeneration.
P2860
The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The safety and utility of reco ...... s in a nonhuman primate model.
@ast
The safety and utility of reco ...... s in a nonhuman primate model.
@en
type
label
The safety and utility of reco ...... s in a nonhuman primate model.
@ast
The safety and utility of reco ...... s in a nonhuman primate model.
@en
prefLabel
The safety and utility of reco ...... s in a nonhuman primate model.
@ast
The safety and utility of reco ...... s in a nonhuman primate model.
@en
P2093
P1476
The safety and utility of reco ...... s in a nonhuman primate model.
@en
P2093
Gregory A Helm
Howard Seeherman
Jonas M Sheehan
P304
P356
10.3171/JNS.2003.98.1.0125
P577
2003-01-01T00:00:00Z